Financial & competing interests disclosure
Kristina Gemzell-Danielsson and Oskari Heikinheimo received support from Bayer Schering Pharma AG (Germany) to conduct the clinical trials that are cited. They also serve on medical advisory boards, and occasionally give presentations for Bayer and MSD. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.